The Effect of Time-restricted Eating on Liver Metabolism
NCT ID: NCT04997486
Last Updated: 2024-11-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
5 participants
INTERVENTIONAL
2021-07-20
2024-03-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Time-Restricted Eating in Cardiometabolic Health
NCT04484987
The Impact of Time Restricted Feeding (TRF) in Improving the Health of Patients With Metabolic Syndrome
NCT03182985
Effects of Early and Delayed Time-restricted Eating in Adults With Overweight and Obesity
NCT04647149
Effect of Time-restricted Eating on Catecholamine-sensitivity of Adipose Tissue in Obese Adults
NCT04916730
Metabolic Impact of Time Restricted Feeding
NCT03129581
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Subjects will consume all meals/snacks during a \~15-h daily eating period (\~9-h fasting). The prescribed energy intake will be monitored and adjusted as needed to achieve weight maintenance.
No interventions assigned to this group
TRE isocaloric
Subjects will consume all meals/snacks during a \~9-h daily eating period (\~15-h fasting). The prescribed energy intake will be monitored and adjusted as needed to achieve weight maintenance.
Time restricted eating
Participants will be asked consume all meals/snacks during a \~9-h daily eating period (\~15-h fasting).
TRE ad libitum
Subjects will consume all meals/snacks during a \~9-h daily eating period (\~15-h fasting) without any other dietary advice.
Time restricted eating
Participants will be asked consume all meals/snacks during a \~9-h daily eating period (\~15-h fasting).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Time restricted eating
Participants will be asked consume all meals/snacks during a \~9-h daily eating period (\~15-h fasting).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* men and women
* body mass index 25-45 kg/m2
* clinical diagnosis of NAFLD
* self-reported habitual eating period more than or equal to 14 h per day.
Exclusion Criteria
* fasting \>12-h/day more than once a week
\*\> once a week no food intake after 18:00
* habitually waking up before 04:00 and sleeping before 22:30
* unstable weight (\>5% change in the last 2 months)
* diabetes mellitus or alcoholic liver disease
* sleep disorder
* history of or current eating disorder
* cancer in last 5 years
* conditions that render subject unable to complete all testing procedures
* use of medications that affect the study outcome measures or increase the risk of study procedures and that cannot be temporarily discontinued
* smoking or illegal drug use
* pregnant or breastfeeding
* having metals in the body
* cognitive impairment
* gastrointestinal or bariatric surgery that affects nutrient digestion and absorption unable to grant voluntary informed consent or comply with the study instructions individuals who are not yet adults (infants, children, teenagers)
* individuals that are unable to lie motionless on the MRI scanner for an hour or \*have tattoos or tattooed eyeliner
* alcohol abuse
* prisoners
25 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, Davis
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of California, Davis
Davis, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1757716
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.